Pennington Biomedical resumed normal operations on Wednesday, August 17. Employees: We understand that many of you are still dealing with difficult situations, so please continue to keep your supervisor informed of your work status.
For updates, employees should call 1-866-412-7272 or visit crisis.pbrc.edu. For a list of storm related information and resources visit:
South Louisiana Flood Info & Resources

PRESS RELEASES

For more information, contact our Communications Office at 225-763-2750 or email news@pbrc.edu with your questions or comments.

Pennington Patent Makes National News

Released: Tuesday, October 21, 2003

The Pennington Biomedical Research Center will be issued a patent for a new cancer treatment that will fight the most common forms – prostate, breast, ovarian and testicular cancer. This new treatment has killed cancerous tumors on laboratory mice while leaving normal cells unaffected. The treatment also destroys mestacized cells which spreads throughout the body and eventually results in death.

According to Pennington research experts, it is difficult to predict exactly when clinicals trials would start, if the drug makes it to that level; perhaps 1 to 3 years. When the drug would be available on a large scale is also difficult to predict. If research is funded, the drug passes all lab and clinical trials and is approved by the FDA, 10 to 12 years is a reasonable estimate.

Please check back for more information.

###

The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. It is a campus of Louisiana State University and conducts basic, clinical and population research. The research enterprise at Pennington Biomedical includes approximately 80 faculty and more than 25 post-doctoral fellows who comprise a network of 44 laboratories supported by lab technicians, nurses, dietitians, and support personnel, and 13 highly specialized core service facilities. Pennington Biomedical’s more than 500 employees perform research activities in state-of-the-art facilities on the 222-acre campus located in Baton Rouge, Louisiana.